Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

The differential diagnosis of papillary tumors of the breast.

KRAUS FT, NEUBECKER RD.

Cancer. 1962 May-Jun;15:444-55. No abstract available.

2.

Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.

Bànkfalvi A, Terpe HJ, Breukelmann D, Bier B, Rempe D, Pschadka G, Krech R, Böcker W.

Histopathology. 1998 Aug;33(2):107-16.

PMID:
9762542
3.

CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.

Guriec N, Marcellin L, Gairard B, Caldéroli H, Wilk A, Renaud R, Bergerat JP, Oberling F.

Clin Exp Metastasis. 1996 Oct;14(5):434-9.

PMID:
8871537
4.

Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.

Regidor PA, Callies R, Regidor M, Günthert U, Zöller M, Schindler AE.

Arch Gynecol Obstet. 1996;258(3):125-35.

PMID:
8781700
5.

A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.

Schumacher U, Horny HP, Horst HA, Herrlich P, Kaiserling E.

Eur J Surg Oncol. 1996 Jun;22(3):259-61.

PMID:
8654608
6.
7.

CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

Friedrichs K, Franke F, Lisboa BW, Kügler G, Gille I, Terpe HJ, Hölzel F, Maass H, Günthert U.

Cancer Res. 1995 Nov 15;55(22):5424-33.

8.

Immunohistochemical analysis of benign and malignant papillary lesions of the breast.

Papotti M, Eusebi V, Gugliotta P, Bussolati G.

Am J Surg Pathol. 1983 Jul;7(5):451-61.

PMID:
6351647
9.

Malignant and benign papillary lesions of the breast.

Murad TM, Swaid S, Pritchett P.

Hum Pathol. 1977 Jul;8(4):379-90.

PMID:
892792

Supplemental Content

Support Center